Searched for
GENERIC DRUG EXCLUSIVITY
Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business press...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: Syngene MDThe recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...
- Dr Reddy's launches generic Revlimid in US market"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bring...
- Ranbaxy Laboratories loses six months exclusivity on Roche's antiviral drug Valcyte"Ranbaxy is disappointed with this development & is actively evaluating all available options to preserve its rights," company said in a st...
- Indian drugmakers switching to fresh strategies as US amends normsIndian generic drug producers are devising fresh strategies to continue benefiting from the world’s largest pharmaceutical market the Unite...
- Mylan sues USFDA for allowing Ranbaxy to sell Diovan's generic versionMylan has sued USFDA for not allowing it to market a generic version of medicine Diovan, saying that Ranbaxy has lost its exclusivity for t...
- Ranbaxy misses out on first-day launch of hypertension drug's generic versionThe company is yet to get the US food and Drug Administration's approval for the generic version of the drug, valsartan.
- Generic vs generic: Drug cos battle to protect turfGeneric drug makers, which have typically waged legal battles against innovator pharma giants, are now suing each other to protect their ma...
- US senators move bill to ban copycat generics productsThree US senators have introduced a bill in the US senate to try and prevent global pharma giants from selling cheaper copies of their own ...
- US court rejects Novartis bid to sell Zocor genericsThe path was cleared for generic versions of Merck’s blockbuster Zocor cholesterol drug on Friday, after a US federal judge rejected a last...
Load More
